Search

Read about Josh Foromera, who was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK.

… Thursday, December 3, 2020 Summary Josh Foromera was born in a small village in Zimbabwe and recently began a fellowship in the Gastroenterology, Hepatology, and Nutrition Service at MSK. On July 1, Josh Foromera moved to New York City to begin his three-year fellowship in the Gastroenterology, Hepatology

The Coalition was discussed at the fourth annual Bloomberg New Economy Forum (NEF) in Singapore on November 16–19.

… Friday, November 19, 2021 Memorial Sloan Kettering Cancer Center (MSK) has joined the Bloomberg New Economy International Cancer Coalition , a multiyear coalition to foster international clinical trial collaboration with the goal of accelerating access, development, and approvals of effective cancer prevention

For the first time, scientists have determined the extent of DNA repair deficiencies across cancer types. Learn what it means for patients.

… Wednesday, October 11, 2017 Summary People with genetic mutations in genes controlling DNA repair may benefit especially well from certain targeted drugs and chemotherapies . A new study has determined how common these mutations are across cancer types. The results pave the way for more tailored cancer

The immune system is a powerful tool for fighting cancer — sometimes too powerful.

… Tuesday, March 8, 2016 Summary When patients receive immunotherapies for cancer, they sometimes experience immune-related side effects, which result from the immune system attacking healthy cells. Two new papers by MSK scientists provide insights into how the immune response can be manipulated to fight

Memorial Sloan Kettering Cancer Center (MSK) today announced the creation of The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project to spur the next revolution of pre-clinical research, discovery, and treatment.

… Thursday, February 3, 2022 Memorial Sloan Kettering Cancer Center (MSK) today announced the creation of The Marie-Josée and Henry R. Kravis Cancer Ecosystems Project to spur the next revolution of preclinical research, discovery, and treatment. The new initiative, made possible by a generous $100 million

Immune cells called neutrophils are the first responders to sites of infection. A new study probes what gets them there.

… Tuesday, May 15, 2018 VIDEO | 00:04 Neutrophil Recruitment — What's Damage Got to Do with It? Video Details Wounding a zebrafish tail fin triggers a wave of calcium (the blue here is a low calcium area; the red, high calcium) that signals damage and recruits neutrophils. Summary Scientists at the Sloan

A drug already approved for anemia offers hope for people with acute myeloid leukemia.

… Monday, March 25, 2019 Summary Leukemia Leukemia cells have an impaired ability to get rid of iron. A nanoparticle drug called ferumoxytol delivers additional iron to these cells. The excess iron causes the leukemia cells to die. Ferumoxytol is already approved to treat anemia, so researchers know the

Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma.

… Wednesday, December 14, 2011 Summary Five Memorial Sloan Kettering scientists have been appointed to a new research team dedicated to identifying targets for therapies to treat a certain form of melanoma. Stand Up To Cancer (SU2C) has appointed five Memorial Sloan Kettering scientists to its new “Dream

In case you missed it, here’s a recap of Monday’s highlights from the American Society of Clinical Oncology annual meeting.

… Tuesday, June 7, 2016 Summary The challenges of using immunotherapy to treat older patients, an update to an important melanoma clinical trial, and a visit from Vice President Joe Biden were among Monday’s highlights at the American Society of Clinical Oncology (ASCO) annual meeting in Chicago. With

On Thursday, June 18th at 6:00 p.m. E.T. with an encore at 9:00 p.m., MSK will stream a special performance highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from its writing program, Visible Ink.

… Thursday, June 18, 2020 On Thursday, June 18 th at 6:00 p.m. E.T. with an encore at 9:00 p.m. , Memorial Sloan Kettering Cancer Center (MSK) will stream a special performance on visibleink.vimeo.mskcc.org , highlighting poignant and humorous perspectives On Cancer and Coronavirus, featuring works from